We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-2.07%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$19.3B
AUM Growth
-$803M
Cap. Flow
+$159M
Cap. Flow %
0.82%
Top 10 Hldgs %
30.79%
Holding
732
New
52
Increased
325
Reduced
233
Closed
41

Top Buys

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$78.3M
2
NEE icon
NextEra Energy
NEE
+$57M
3
NVDA icon
NVIDIA
NVDA
+$48M
4
BABA icon
Alibaba
BABA
+$43.4M
5
AAPL icon
Apple
AAPL
+$39M

Top Sells

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$87.5M
2
RVMD icon
Revolution Medicines
RVMD
+$45.5M
3
ABT icon
Abbott
ABT
+$44.5M
4
JPM icon
JPMorgan Chase
JPM
+$44.3M
5
IQV icon
IQVIA
IQV
+$43M

Sector Composition

Rank Sector Weight
1 Technology 32.73%
2 Healthcare 27.11%
3 Financials 9.44%
4 Consumer Discretionary 7.72%
5 Communication Services 7.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VERA icon
201
Vera Therapeutics
VERA
$2.67B
$19.1M 0.1%
475,335
+25,781
+6% +$1.11M
TXN icon
202
Texas Instruments
TXN
$265B
$18.9M 0.1%
97,367
+3,023
+3% +$612K
APGE icon
203
Apogee Therapeutics
APGE
$10.1B
$18.8M 0.1%
223,541
+32,223
+17% +$2.34M
JXN icon
204
Jackson Financial
JXN
$8.66B
$18.8M 0.1%
177,950
+42,607
+31% +$4.77M
NTRS icon
205
Northern Trust
NTRS
$34.2B
$18.6M 0.1%
132,919
+74,196
+126% +$10.7M
PCVX icon
206
Vaxcyte
PCVX
$8.38B
$18.3M 0.1%
+315,022
New +$17.1M
NEM icon
207
Newmont
NEM
$98.7B
$18.2M 0.09%
168,137
+15,201
+10% +$1.75M
FTV icon
208
Fortive
FTV
$18.5B
$18.1M 0.09%
327,358
+262,471
+405% +$14.7M
DNTH icon
209
Dianthus Therapeutics
DNTH
$5.78B
$17.9M 0.09%
213,522
-97,628
-31% -$5.65M
FIS icon
210
Fidelity National Information Services
FIS
$21.5B
$17.6M 0.09%
375,784
+321,624
+594% +$17.3M
CIB icon
211
Grupo Cibest SA
CIB
$19.8B
$17.5M 0.09%
240,556
-249,900
-51% -$18.4M
NTRA icon
212
Natera
NTRA
$38.3B
$17.1M 0.09%
85,677
-13,469
-14% -$2.9M
RCUS icon
213
Arcus Biosciences
RCUS
$3.71B
$17.1M 0.09%
790,613
– –
IMVT icon
214
Immunovant
IMVT
$8.12B
$16.9M 0.09%
680,372
– –
ANET icon
215
Arista Networks
ANET
$220B
$16.9M 0.09%
137,440
+19,505
+17% +$2.61M
KYMR icon
216
Kymera Therapeutics
KYMR
$9.33B
$16.8M 0.09%
201,672
– –
T icon
217
AT&T
T
$155B
$16.8M 0.09%
579,088
+20,075
+4% +$536K
CCK icon
218
Crown Holdings
CCK
$13.2B
$16.7M 0.09%
166,333
-61,874
-27% -$6.61M
MGA icon
219
Magna International
MGA
$18.5B
$16.5M 0.09%
297,267
+21,630
+8% +$1.24M
STOK icon
220
Stoke Therapeutics
STOK
$1.79B
$16.3M 0.08%
502,020
+55,330
+12% +$1.81M
CHE icon
221
Chemed
CHE
$6.69B
$16.3M 0.08%
43,242
-12,989
-23% -$5.56M
TGT icon
222
Target
TGT
$62.9B
$16.2M 0.08%
133,740
-270,809
-67% -$30.5M
INTC icon
223
Intel
INTC
$530B
$16M 0.08%
363,368
+9,948
+3% +$456K
SQM icon
224
Sociedad Química y Minera de Chile
SQM
$19.7B
$16M 0.08%
197,600
-59,000
-23% -$4.49M
TMDX icon
225
Transmedics
TMDX
$2.57B
$15.8M 0.08%
158,766
+49,580
+45% +$6.47M
7 8
9
10 11

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2026 Portfolio in Review

As of Q1 2026, Candriam SCA held 732 positions worth $19.3B, down 4% from $20.1B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Candriam SCA's Q1 2026 filing shows 52 new, 325 increased, 233 reduced and 41 closed positions. Its largest new stake was Service Corp International: 360,195 shares worth $29.7M. The largest sale was Nu Holdings, an estimated $87.5M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q1 2026 buy was Service Corp International: 360,195 shares worth $29.7M.
  • Candriam SCA added most to KLA in Q1 2026, an estimated $78.3M increase.
  • Candriam SCA's biggest Q1 2026 reduction was Nu Holdings, cutting an estimated $87.5M.
  • Candriam SCA fully exited Banco Macro in Q1 2026, selling an estimated $25.6M.
  • Candriam SCA's ten largest holdings make up 31% of its $19.3B portfolio in Q1 2026.
  • Candriam SCA opened 52 new positions and closed 41 in Q1 2026.
  • Candriam SCA's portfolio value fell 4% quarter-over-quarter to $19.3B.

Based on Candriam SCA's 13F filing for Q1 2026, filed 30 Apr 2026.